Wildlife population management are contraceptive vaccines a feasible proposition
| Autor: | Vidisha Minhas, Satish K. Gupta |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Conservation of Natural Resources Porcine zona pellucida media_common.quotation_subject Population Wildlife Animals Wild Fertility Gonadotropin-releasing hormone Bioinformatics General Biochemistry Genetics and Molecular Biology 03 medical and health sciences Immune system Animals Medicine Vaccines Contraceptive Population management Contraception Immunologic education media_common education.field_of_study General Immunology and Microbiology Safety studies business.industry Environmental resource management 030104 developmental biology Female business |
| Zdroj: | Frontiers in Bioscience. 9:357-374 |
| ISSN: | 1945-0524 1945-0516 |
| DOI: | 10.2741/s492 |
| Popis: | To minimize human-animal conflicts for habitation and burden of zoonotic diseases, it is imperative to develop new strategies for wildlife population management. In this direction, contraceptive vaccines eliciting immune response against hormones/proteins critical for reproduction have emerged as one of the promising options. Contraceptive vaccines based on neutralization of gonadotropin releasing hormone (GnRH) have been used for inhibition of fertility in various species such as wild horses, white-tailed deer, pigs, cats, dogs etc. It has been used for immunocastration of male pigs to improve meat quality. However, additional safety studies of GnRH vaccine will be needed in light of presence of its receptor at extra-pituitary sites. Native porcine zona pellucida (PZP)-based contraceptive vaccines have shown their utility in the management of the population of both captive and free-ranging wild horses and white-tailed deer. Long-term use of the PZP-based contraceptive vaccines has also demonstrated their safety. Ideally single injection of the contraceptive vaccine should elicit long lasting immune response and desired contraceptive efficacy, which will require development of novel vaccine delivery platforms and more potent adjuvants. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|